Biogen to Present New Results for Spinraza, Other Treatments for Neurological Diseases

Biogen announced the presentation of new data from its current treatments and investigational therapies for neurological and neurodegenerative diseases at the 69th annual meeting of the American Academy of Neurology (AAN) April 22-28 in Boston. The presentations will include new data on Spinraza. Biogen will present data…